Literature DB >> 11969307

Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.

Howard C Haspel1, Gloria M Scicli, Gerald McMahon, A Guillermo Scicli.   

Abstract

The angiogenic vascular endothelial growth factor (VEGF) is believed to play a critical role in endothelial cell proliferation, differentiation, and sprouting. Small molecules that selectively inhibit the VEGF receptor-associated tyrosine kinase activities of Flk-1 (KDR) and Flt-1 have been developed. These agents, a prototype being SU5416, have effects on the proliferation of cultured endothelial cells, constrain angiogenesis in vivo, and have been proposed as antitumor drugs. Although SU5416 inhibits in vivo angiogenesis, it is not clear which of the complex processes leading to angiogenesis are impacted by VEGF receptor-associated tyrosine kinase inhibition. We utilized SU5416 and a microvascular endothelial cell line derived from mouse heart (SMHEC4) to specifically examine the role of VEGF receptor-associated tyrosine kinase activity on in vitro models of angiogenesis. We characterized spheroid formation and sprouting, a new model of angiogenesis, in this stable cell line. SU5416 inhibits (approximately 50%) VEGF (50 ng/ml) stimulated and basal DNA synthesis of SMHEC4 cultured in monolayer. SU5416 does not prevent the aggregation and organization of SMHEC4 into tri-dimensional spheroids. CD31, a marker of differentiated endothelial cells, is negligibly expressed in monolayer cultures but highly expressed in SMHEC4 spheroids. The content and biochemical characteristics of spheroidal CD31 are unaltered by SU5416. SU5416 also does not prevent the spontaneous and rapid (approximately 3-h) alignment into cords by SMHEC4 on Matrigel. These two models suggest that the organization and differentiation of endothelial cells is independent of VEGF receptor-associated tyrosine kinase signaling. SMHEC4 spheroids embedded in collagen gels spontaneously and rapidly (approximately 6 h) sprout capillary-like projections and subsequently (1-2 days) form complex self-anastomosing networks. In addition, VEGF (50 ng/ml) markedly stimulates sprouting of capillary-like projections from SMHEC4 spheroids. Both the spontaneous and the VEGF-stimulated sprouting are nearly eliminated by SU5416. This demonstrates that VEGF receptor-associated tyrosine kinase activity is essential to the formation of capillary-like structures from SMHEC4 spheroids. Overall, these observations demonstrate that (a) the spheroid sprouting model is appropriate for the study of angiogenesis since it appears to recapitulate many of its steps and (b) SU5416 can inhibit endothelial cell proliferation and sprouting without impacting the organization and differentiation of endothelial cells. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11969307     DOI: 10.1006/mvre.2001.2383

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  11 in total

1.  Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.

Authors:  Tetsuya Hirabayashi; Haruka Takahashi; Miho Watanabe; Toshiaki Tachibana
Journal:  Hum Cell       Date:  2017-03-04       Impact factor: 4.174

2.  Use of PROTACS as molecular probes of angiogenesis.

Authors:  Paola Bargagna-Mohan; Sun-Hee Baek; Hyosung Lee; Kyungbo Kim; Royce Mohan
Journal:  Bioorg Med Chem Lett       Date:  2005-06-02       Impact factor: 2.823

3.  SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells.

Authors:  Nishant Mohan; Surajit Karmakar; Naren L Banik; Swapan K Ray
Journal:  Neurochem Res       Date:  2011-04-07       Impact factor: 3.996

4.  Paper-based in vitro tissue chip for delivering programmed mechanical stimuli of local compression and shear flow.

Authors:  Kattika Kaarj; Marianne Madias; Patarajarin Akarapipad; Soohee Cho; Jeong-Yeol Yoon
Journal:  J Biol Eng       Date:  2020-07-28       Impact factor: 4.355

5.  Paracrine induction of endothelium by tumor exosomes.

Authors:  Joshua L Hood; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Lab Invest       Date:  2009-09-28       Impact factor: 5.662

6.  Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays.

Authors:  David G Belair; Michael P Schwartz; Thomas Knudsen; William L Murphy
Journal:  Acta Biomater       Date:  2016-05-13       Impact factor: 8.947

7.  Human vascular tissue models formed from human induced pluripotent stem cell derived endothelial cells.

Authors:  David G Belair; Jordan A Whisler; Jorge Valdez; Jeremy Velazquez; James A Molenda; Vernella Vickerman; Rachel Lewis; Christine Daigh; Tyler D Hansen; David A Mann; James A Thomson; Linda G Griffith; Roger D Kamm; Michael P Schwartz; William L Murphy
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

8.  Embedded Spheroids as Models of the Cancer Microenvironment.

Authors:  Kristie M Tevis; Yolonda L Colson; Mark W Grinstaff
Journal:  Adv Biosyst       Date:  2017-08-18

9.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2.

Authors:  S M Sagar; D Yance; R K Wong
Journal:  Curr Oncol       Date:  2006-06       Impact factor: 3.677

10.  In vivo engineering of a human vasculature for bone tissue engineering applications.

Authors:  Lilian Steffens; Andreas Wenger; G Björn Stark; Günter Finkenzeller
Journal:  J Cell Mol Med       Date:  2009-06-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.